| Anlon Healthcare Ltd | Industry : (Chemicals) | |
|---|---|---|
|
BSE Code : 544497 |
NSE Symbol : AHCL |
P/E(TTM) : 18.61 |
|
ISIN Demat : INE0Y8W01017 |
Div & Yield% : 0.00 |
EPS(TTM) : 6.52 |
|
Book Value(₹) : 40.32 |
Market Cap(₹Cr) : 644.99 |
Face Value(₹) : 10.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 35.58 | 52.20 | 33.30 | 48.93 | 9.36 | 24.17 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 35.58 | 52.20 | 33.30 | 48.93 | 9.36 | 24.17 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.20 | 0.03 | 0.01 | 0.04 | 0.02 | 0.05 |
| Total Income | 35.78 | 52.23 | 33.31 | 48.97 | 9.38 | 24.21 |
| Total Expenditure | 23.24 | 38.46 | 27.06 | 31.74 | 8.78 | 16.64 |
| PBIDT | 12.54 | 13.77 | 6.25 | 17.23 | 0.60 | 7.57 |
| Interest | 1.58 | 0.87 | 0.82 | 0.91 | 0.89 | 0.93 |
| PBDT | 10.97 | 12.90 | 5.43 | 16.32 | -0.29 | 6.64 |
| Depreciation | 0.35 | 0.45 | 0.43 | 0.83 | 0.00 | 0.47 |
| Tax | 5.28 | 3.16 | 1.48 | -1.04 | 2.21 | 3.59 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.18 | -0.03 | -0.02 | -0.12 | -0.01 | -0.02 |
| Reported Profit After Tax | 5.15 | 9.32 | 3.55 | 16.65 | -2.49 | 2.59 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 5.15 | 9.32 | 3.55 | 16.65 | -2.49 | 2.59 |
| EPS (Unit Curr.) | 1.13 | 2.22 | 0.89 | 4.18 | -0.83 | 0.41 |
| EPS (Adj) (Unit Curr.) | 1.13 | 2.22 | 0.89 | 4.18 | -0.83 | 0.41 |
| Calculated EPS (Unit Curr.) | 0.97 | 1.75 | 0.67 | 4.18 | -0.62 | 0.65 |
| Calculated EPS (Adj) (Unit Curr.) | 0.97 | 1.75 | 0.67 | 4.18 | -0.62 | 0.65 |
| Calculated EPS (Ann.) (Unit Curr.) | 3.88 | 7.01 | 2.67 | 16.71 | -2.49 | 2.60 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 3.88 | 7.01 | 2.67 | 16.71 | -2.49 | 2.60 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 53.15 | 53.15 | 53.15 | 39.85 | 39.85 | 39.85 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 35.24 | 26.38 | 18.77 | 35.21 | 6.41 | 31.32 |
| PBDTM(%) | 30.83 | 24.71 | 16.31 | 33.35 | -3.10 | 27.47 |
| PATM(%) | 14.47 | 17.85 | 10.66 | 34.03 | -26.60 | 10.72 |
